Skip to Content
  • Previous Rank-
  • Revenues ($M)$1,848
  • Revenue Percent Change0.9%
  • Profits ($M)$111.5
  • Profits Percent Change-47.5%
  • Assets ($M)$3,091
  • Employees9,200
  • Market Value — as of March 31, 2017 ($M)$3,534
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John R. Chiminski
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Somerset, NJ
Websitehttp://www.catalent.com
Years on Fortune 500 List-
Employees9,200
Figures are for fiscal year ended June 30, 2016.

Catalent Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$1,8480.9%
Profits ($M)$111.5-47.5%
Assets ($M)$3,091-
Total Stockholder Equity ($M)$636-
Market Value — as of March 31, 2017 ($M)$3,534-

Profit Ratios

Profit as % of Revenues6%
Profits as % of Assets3.6%
Profits as % of Stockholder Equity17.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.89
EPS % Change (from 2015)-49.1%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2016)7.7%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-